Introduction
Poly-L-lactic acid (Sculptra®, PLLA-SCA®, Galderma Laboratories, Lausanne, Switzerland) is an alpha-hydroxy acid that has been in clinical use for many years, since its introduction in Europe in 1999. PLLA-SCA is a biocompatible…
Blog
-
Nashville’s New Year’s Eve 2025–Hundreds of Officers Working to Help Ensure Safety
Hundreds of Metro police officers will be highly visible as they work New Year’s Eve assignments downtown, at the Bicentennial Mall and the Gulch area to help ensure the safety of Nashvillians and visitors attending “Nashville’s Big Bash”…
Continue Reading
-
Anthony Joshua: British boxer injured in car crash that killed two friends in Nigeria
Former world heavyweight boxing champion Anthony Joshua escaped with minor injuries in a car crash that killed two of his friends and team members on Monday, according to Nigerian authorities and his promoter.
…Continue Reading
-
Brigitte Bardot was the face of France
Brigitte Bardot was one of France’s greatest film stars. Yet her film career was relatively short, running from the mid-1950s to the early 1970s. By comparison, Catherine Deneuve has been a constant presence on the screen since her…
Continue Reading
-
Parents first, royals second: how Prince William and Kate Middleton have made it clear that family life is their priority
‘I think it would surprise people to see how ordinary things are at home,’ an insider told MailOnline, noting that the young Princes and Princess are expected to chip in with chores and help around the house. It’s understood that this…
Continue Reading
-
Pakistan stocks hit record high on UAE investment optimism – Arab News
- Pakistan stocks hit record high on UAE investment optimism Arab News
- KSE-100 hits new all-time high on nearly 1,500-point rally Business Recorder
- PIA deal propels PSX to record high in rollover week Dawn
- Weekly Market Roundup Mettis Global
- PSX Settles At New All-Time High on UAE’s Billion-Dollar Investment News ProPakistani
Continue Reading
-
Sameer Minhas Equals Babar Azam’s Record in Just Seven Matches
Pakistan’s U19 star Sameer Minhas continues to make headlines, having already written his name alongside some of the country’s most celebrated cricketers, and he has done it at remarkable speed.
In just seven Youth ODI appearances, Sameer…
Continue Reading
-
MetaVia to Participate in and Sponsor the 10th Annual MASH-TAG 2026 Conference
CAMBRIDGE, Mass., Dec. 29, 2025 /PRNewswire/ — MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it will participate in and sponsor the 10th Annual MASH-TAG 2026 Conference. Members of MetaVia’s business development and clinical teams will attend the conference, which will take place January 8-10 at the Chateaux Deer Valley in Park City, Utah.
About MetaVia
MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is currently developing DA-1726 for the treatment of obesity, and is developing vanoglipel (DA-1241) for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH). DA-1726 is a novel oxyntomodulin (OXM) analogue that functions as a glucagon-like peptide-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist. OXM is a naturally-occurring gut hormone that activates GLP1R and GCGR, thereby decreasing food intake while increasing energy expenditure, thus potentially resulting in superior body weight loss compared to selective GLP1R agonists. In a Phase 1 multiple ascending dose (MAD) trial in obesity, DA-1726 demonstrated best-in-class potential for weight loss, glucose control, and waist reduction. Vanoglipel is a novel G-protein-coupled receptor 119 (GPR119) agonist that promotes the release of key gut peptides GLP-1, GIP, and PYY. In pre-clinical studies, vanoglipel demonstrated a positive effect on liver inflammation, lipid metabolism, weight loss, and glucose metabolism, reducing hepatic steatosis, hepatic inflammation, and liver fibrosis, while also improving glucose control. In a Phase 2a clinical study, vanoglipel demonstrated direct hepatic action in addition to its glucose lowering effects.For more information, please visit www.metaviatx.com.
Contacts:
MetaVia
Marshall H. Woodworth
Chief Financial Officer
+1-857-299-1033
[email protected]Rx Communications Group
Michael Miller
+1-917-633-6086
[email protected]SOURCE MetaVia Inc.
Continue Reading
-
Infinix Note Edge Appears in Fresh Leak with Curved AMOLED Display
The Infinix Note Edge has surfaced in a new leak after appearing earlier this month in Indonesia’s SDPPI certification database. The latest information comes from tipster Paras Guglani, who shared an image and several specifications on X.
…
Continue Reading
-
5 Anti-Inflammatory Fruits to Eat This January
- Inflammation risk can go up in the winter, and what you eat is important to keep it in check.
- Choosing colorful fruits help reduce inflammation and deliver other key nutrients.
- These fruits, including grapefruit and kiwi, are in season during…
Continue Reading